Pulmonary alveolar microlithiasis

Patrick Kosciuk, Cristopher Meyer, Kathryn A. Wikenheiser-Brokamp, Francis X. McCormack

Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020
Journal Issue: December
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Patrick Kosciuk, Cristopher Meyer, Kathryn A. Wikenheiser-Brokamp, Francis X. McCormack. Pulmonary alveolar microlithiasis. Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary alveolar microlithiasis (PAM)
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001

Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009

Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011



Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Pulmonary alveolar microlithiasis: a case report
Source: Eur Respir J 2004; 24: Suppl. 48, 489s
Year: 2004

Pulmonary alveolar microlithiasis: case report
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



Pulmonary alveolar microlithiasis with pleural, periurethral and epididymal calcifications
Source: Eur Respir J 2001; 18: Suppl. 33, 512s
Year: 2001

Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 215; 10.1183/20734735.0018-2020
Year: 2020



Clinical characteristics of pulmonary alveolar microlithiasis in Japan
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

New mutation associated to the pulmonary alveolar microlithiasis
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Pulmonary alveolar microlithiasis: no longer in the stone age
Source: ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020
Year: 2020



Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

First presentation of a case of pulmonary alveolar microlithiasis with spontaneous pneumothorax
Source: Annual Congress 2012 - The good clinical practice: useful case report
Year: 2012

Idiopathic alveolar lipoproteinosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008